Annual Operating Expenses:
$181.59M+$27.94M(+18.18%)Summary
- As of today, PTGX annual total operating expenses is $181.59 million, with the most recent change of +$27.94 million (+18.18%) on December 31, 2024.
- During the last 3 years, PTGX annual operating expenses has risen by +$28.39 million (+18.53%).
- PTGX annual operating expenses is now at all-time high.
Performance
PTGX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Operating Expenses:
$50.77M+$3.49M(+7.38%)Summary
- As of today, PTGX quarterly total operating expenses is $50.77 million, with the most recent change of +$3.49 million (+7.38%) on September 30, 2025.
- Over the past year, PTGX quarterly operating expenses has increased by +$5.29 million (+11.63%).
- PTGX quarterly operating expenses is now at all-time high.
Performance
PTGX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
PTGX Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +18.2% | +11.6% |
| 3Y3 Years | +18.5% | +61.4% |
| 5Y5 Years | +124.9% | +529.0% |
PTGX Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +18.5% | at high | +61.4% |
| 5Y | 5-Year | at high | +124.9% | at high | +529.0% |
| All-Time | All-Time | at high | +1848.6% | at high | +1829.8% |
PTGX Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $50.77M(+7.4%) |
| Jun 2025 | - | $47.28M(-0.2%) |
| Mar 2025 | - | $47.39M(+9.6%) |
| Dec 2024 | $181.59M(+18.2%) | $43.25M(-4.9%) |
| Sep 2024 | - | $45.48M(+8.1%) |
| Jun 2024 | - | $42.07M(-12.0%) |
| Mar 2024 | - | $47.82M(+32.4%) |
| Dec 2023 | $153.65M(-2.7%) | $36.12M(-3.7%) |
| Sep 2023 | - | $37.50M(-9.7%) |
| Jun 2023 | - | $41.53M(+18.0%) |
| Mar 2023 | - | $35.19M(-3.0%) |
| Dec 2022 | $157.95M(+3.1%) | $36.26M(+15.3%) |
| Sep 2022 | - | $31.45M(-24.1%) |
| Jun 2022 | - | $41.46M(-9.9%) |
| Mar 2022 | - | $46.00M(+0.6%) |
| Dec 2021 | $153.20M(+64.5%) | $45.71M(+32.8%) |
| Sep 2021 | - | $34.43M(+7.6%) |
| Jun 2021 | - | $31.98M(+28.3%) |
| Mar 2021 | - | $24.92M(+32.3%) |
| Dec 2020 | $93.14M | $18.83M(+133.3%) |
| Sep 2020 | - | $8.07M(-56.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | $18.42M(-8.8%) |
| Mar 2020 | - | $20.20M(+16.8%) |
| Dec 2019 | $80.75M(+10.3%) | $17.30M(-2.6%) |
| Sep 2019 | - | $17.77M(-46.9%) |
| Jun 2019 | - | $33.47M(+119.0%) |
| Mar 2019 | - | $15.28M(-0.9%) |
| Dec 2018 | $73.19M(+26.3%) | $15.41M(+64.1%) |
| Sep 2018 | - | $9.39M(+1.6%) |
| Jun 2018 | - | $9.24M(+12.3%) |
| Mar 2018 | - | $8.23M(+134.2%) |
| Dec 2017 | $57.96M(+77.4%) | $3.51M(-29.5%) |
| Sep 2017 | - | $4.98M(-66.9%) |
| Jun 2017 | - | $15.04M(+6.0%) |
| Mar 2017 | - | $14.19M(+25.3%) |
| Dec 2016 | $32.67M(+120.8%) | $11.32M(+60.5%) |
| Sep 2016 | - | $7.05M(+0.7%) |
| Jun 2016 | - | $7.00M(+0.5%) |
| Mar 2016 | - | $6.97M(+164.8%) |
| Dec 2015 | $14.79M(+58.8%) | - |
| Mar 2015 | - | $2.63M |
| Dec 2014 | $9.32M | - |
FAQ
- What is Protagonist Therapeutics, Inc. annual total operating expenses?
- What is the all-time high annual operating expenses for Protagonist Therapeutics, Inc.?
- What is Protagonist Therapeutics, Inc. annual operating expenses year-on-year change?
- What is Protagonist Therapeutics, Inc. quarterly total operating expenses?
- What is the all-time high quarterly operating expenses for Protagonist Therapeutics, Inc.?
- What is Protagonist Therapeutics, Inc. quarterly operating expenses year-on-year change?
What is Protagonist Therapeutics, Inc. annual total operating expenses?
The current annual operating expenses of PTGX is $181.59M
What is the all-time high annual operating expenses for Protagonist Therapeutics, Inc.?
Protagonist Therapeutics, Inc. all-time high annual total operating expenses is $181.59M
What is Protagonist Therapeutics, Inc. annual operating expenses year-on-year change?
Over the past year, PTGX annual total operating expenses has changed by +$27.94M (+18.18%)
What is Protagonist Therapeutics, Inc. quarterly total operating expenses?
The current quarterly operating expenses of PTGX is $50.77M
What is the all-time high quarterly operating expenses for Protagonist Therapeutics, Inc.?
Protagonist Therapeutics, Inc. all-time high quarterly total operating expenses is $50.77M
What is Protagonist Therapeutics, Inc. quarterly operating expenses year-on-year change?
Over the past year, PTGX quarterly total operating expenses has changed by +$5.29M (+11.63%)